Can You Take Lion's Mane Every Day? Safety Evidence

Lion's Mane Dosing & Safety

49 Weeks

The longest published RCT of daily lion's mane supplementation ran 49 weeks with erinacine A-enriched mycelia capsules. No serious adverse events were attributed to the supplement.

Li et al., Front Aging Neurosci, 2020

5 RCTs

have tested daily lion's mane supplementation in humans (4-49 weeks)

Mild GI Only

abdominal discomfort and diarrhea are the only documented side effects

1-3g/day

dose range used in most clinical trials

Li et al., Front Aging Neurosci, 2020

View as image ↗

Lion's mane (Hericium erinaceus) is consumed daily by millions of people as a supplement, and a growing number of clinical trials have tested daily administration for periods ranging from 4 to 49 weeks. The safety record across these trials is reassuring: no serious adverse events have been attributed to lion's mane in any published RCT, and the only documented side effects are mild gastrointestinal symptoms. What the evidence does not show is whether daily use for years (rather than weeks or months) is safe, because no trial has run that long. The distinction matters because most supplement users continue daily consumption indefinitely, well beyond the duration of any published study. For a complete side effect review, see lion's mane side effects: what the research says about safety.

The 2025 Systematic Review: 26 Studies Assessed

Menon et al. (2025) published the most comprehensive systematic review of lion's mane as a supplement, covering 26 studies published between 2000 and 2024.^[1] The review included 5 randomized controlled trials, 15 laboratory studies, 3 pilot clinical trials, 1 cohort study, 1 case report, and 1 computational analysis. The aim was to establish a safety profile for lion's mane supplementation based on all available evidence.

The findings on side effects were straightforward: documented adverse effects were limited to mild gastrointestinal symptoms (abdominal discomfort and diarrhea). No serious adverse events were reported in any study included in the review. No hepatotoxicity, nephrotoxicity, cardiotoxicity, or neurotoxicity was identified.

The review noted that clinical trials have included small numbers of participants with short durations, and concluded that "well-designed larger and longer clinical trials are needed" to fully establish long-term safety. The dose range across studies was 1.8-10 grams per day for healthy adults, with most studies using 1.8-3 grams daily.

The Longest Trial: 49 Weeks of Daily Use

Li et al. (2020) conducted the longest published RCT of daily lion's mane supplementation: a 49-week double-blind, placebo-controlled study in patients with mild Alzheimer's disease.^[2] Patients received three capsules per day of erinacine A-enriched H. erinaceus mycelia (EAHE, 350 mg per capsule, containing 5 mg/g erinacine A) or identical placebo.

Over nearly a full year of daily administration, no serious adverse events were attributed to EAHE. The supplement was well-tolerated in an elderly, cognitively impaired population that is generally more vulnerable to adverse drug effects than healthy adults. Cognitive scores improved in the EAHE group while the placebo group declined. Biomarkers including BDNF, amyloid-beta 1-40, and other metabolic markers were tracked throughout, and no concerning laboratory trends emerged.

This 49-week duration is the closest available approximation to what long-term daily users experience, though it is still shorter than the years-long supplementation patterns many consumers follow. For the cognitive findings from this trial, see how to take lion's mane: timing, cycling, and best practices.

The Cognitive Impairment Trial: 16 Weeks with Laboratory Monitoring

Mori et al. (2009) conducted a landmark double-blind, placebo-controlled trial in 30 Japanese men and women aged 50-80 with mild cognitive impairment.^[3] The Yamabushitake group received four 250 mg tablets containing 96% lion's mane dry powder three times daily (total 3 grams per day) for 16 weeks, followed by a 4-week observation period.

Laboratory tests showed no adverse effects of lion's mane at any time point during the 16 weeks of supplementation. Cognitive function scores increased significantly at weeks 8, 12, and 16 in the lion's mane group compared to placebo. After the 16-week intake period, when supplementation was stopped, cognitive scores decreased significantly, suggesting that the cognitive benefits require continued use.

The reversibility of cognitive benefits after stopping is relevant to the safety question indirectly: it means there is no evidence of lasting neurological changes from 16 weeks of daily lion's mane consumption. The brain returned to its pre-supplementation state within 4 weeks, suggesting the effects are pharmacological (present while the compound is active) rather than structural (permanent changes to brain tissue).

Healthy Young Adults: 28-Day RCT

Docherty et al. (2023) tested lion's mane in the population most commonly buying it as a supplement: healthy young adults.^[4] This randomized, double-blind, placebo-controlled, parallel-group design tested 1.8 grams per day of lion's mane extract for 28 days.

No adverse events were reported. Cognitive testing showed improvements in processing speed emerging by day 28 in the lion's mane group. Stress and mood measures were also assessed. The short duration limits what the study can say about long-term safety, but it confirms that 1.8 g/day in healthy adults produces no detectable harm over four weeks.

Surendran et al. (2025) conducted an acute, single-dose study of standardized lion's mane extract in healthy younger adults, demonstrating that even acute dosing produces no adverse cognitive or mood effects.^[5]

The Mood and Sleep Trial: 8 Weeks in Overweight Adults

Vigna et al. (2019) tested lion's mane in 77 overweight or obese volunteers with mood and sleep disorders at the IRCCS Foundation Policlinico Hospital of Milan.^[6] After 8 weeks of oral supplementation, participants showed decreased depression, anxiety, and improved sleep quality. Circulating BDNF levels were modulated alongside the clinical improvements.

No safety concerns were reported. This study is relevant because overweight and obese individuals often have comorbidities (metabolic syndrome, insulin resistance, cardiovascular risk factors) that could theoretically interact with supplement use. The absence of adverse events in this population extends the safety data beyond healthy volunteers and cognitively impaired elderly.

Historical Safety: Food Use Across Centuries

Lion's mane has been consumed as food in China, Japan, and Korea for centuries. Friedman (2015) documented its long history of culinary and medicinal use across East Asia, noting that it is eaten fresh, dried, or as a tea ingredient.^[7] As a food, lion's mane has a different risk profile than as a concentrated extract: whole mushroom consumption delivers lower concentrations of individual bioactive compounds than standardized extracts.

He et al. (2017) reviewed the structural diversity of lion's mane polysaccharides and noted that the biological activities and safety depend on extraction methods, growth substrates, and whether fruiting body or mycelium preparations are used.^[8] This variability means that safety data from one formulation do not automatically apply to others. A trial using 96% fruiting body powder may not have the same safety profile as a trial using erinacine A-enriched mycelium extract.

Contato and Conte-Junior (2025) confirmed in their narrative review that lion's mane is "an edible, medicinal fungus" with a strong safety record across both traditional use and modern clinical research.^[9]

What the Evidence Does Not Cover

Xu et al. (1985) published one of the earliest clinical studies of lion's mane for chronic atrophic gastritis, establishing a decades-long track record of human use in clinical settings.^[10] But even combining the earliest studies with the most recent, several gaps remain:

• Multi-year daily use: The longest RCT is 49 weeks. Most consumers take lion's mane for years. No study has monitored safety beyond one year
• High-dose safety: Most trials use 1-3 grams daily. Some commercial products recommend higher doses. Safety at 5-10 grams daily long-term is unstudied
• Drug interactions: No clinical trial has systematically tested lion's mane alongside common medications (statins, blood thinners, antidiabetics)
• Pregnancy and lactation: No safety data exist for these populations
• Immunocompromised patients: Lion's mane's immunomodulatory effects could theoretically be problematic in autoimmune conditions or organ transplant recipients on immunosuppressants

For dosing recommendations based on available evidence, see lion's mane dosage guide: how much should you take?, and for form comparisons, see lion's mane extract vs. powder: which form is more effective?.

The Bottom Line

Five randomized controlled trials testing daily lion's mane for 4-49 weeks have reported no serious adverse events. The only documented side effects are mild gastrointestinal symptoms. A 2025 systematic review of 26 studies confirmed this safety profile. The longest trial (49 weeks) tracked cognitive, metabolic, and safety outcomes without concerns. Gaps remain for multi-year use, high-dose safety, drug interactions, and special populations.

Frequently Asked Questions

Is it safe to take lion's mane every day?

Five published RCTs have tested daily lion's mane for periods of 4 to 49 weeks, with no serious adverse events in any trial (Menon et al., 2025). The only documented side effects are mild abdominal discomfort and diarrhea. The longest study (49 weeks of erinacine A mycelia capsules) showed no safety concerns in mild Alzheimer's patients (Li et al., 2020). No study has monitored daily use beyond one year.

How much lion's mane can you take daily?

Most clinical trials have used 1-3 grams of lion's mane per day (Mori et al., 2009; Docherty et al., 2023). The 2025 systematic review noted a tested dose range of 1.8-10 grams daily across studies (Menon et al., 2025). Safety at doses above 3 grams daily has less clinical evidence than the 1-3 gram range.

What are the side effects of lion's mane?

Documented side effects from clinical trials are limited to mild gastrointestinal symptoms: abdominal discomfort and diarrhea. In the Mori et al. (2009) trial (3 grams daily for 16 weeks), laboratory tests showed no adverse effects on blood chemistry, liver function, or kidney function. No serious adverse events have been reported in any published RCT.

Do you need to cycle lion's mane?

No clinical evidence supports a need for cycling. The longest continuous daily supplementation in an RCT was 49 weeks without safety concerns (Li et al., 2020). In the Mori et al. (2009) trial, cognitive benefits disappeared within 4 weeks of stopping, suggesting that continuous use is necessary to maintain effects. No study has tested cycling protocols against continuous use.

Can lion's mane interact with medications?

No clinical trial has systematically tested lion's mane alongside common medications. Theoretical interaction concerns exist for anticoagulants (lion's mane may have mild platelet aggregation-inhibiting effects) and immunosuppressants (due to immunomodulatory properties). The 49-week Alzheimer's trial enrolled patients who may have been on other medications, but interaction data were not specifically reported (Li et al., 2020).

Is lion's mane safe for elderly people?

Two RCTs specifically enrolled elderly participants. Mori et al. (2009) tested 3 grams daily in adults aged 50-80 with mild cognitive impairment for 16 weeks with no adverse effects. Li et al. (2020) tested erinacine A mycelia capsules for 49 weeks in mild Alzheimer's patients with no serious adverse events. These trials provide moderate evidence of safety in older adults.

Sources & References

1. 1RTHM-00943·Menon, Arya et al. (2025). “Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review..” Frontiers in nutrition.Study breakdown →PubMed →↩
2. 2RTHM-00631·Li, I-Chen et al. (2020). “Prevention of Early Alzheimer's Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study..” Frontiers in aging neuroscience.Study breakdown →PubMed →↩
3. 3RTHM-00165·Mori, Koichiro et al. (2009). “Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial..” Phytotherapy research : PTR.Study breakdown →PubMed →↩
4. 4RTHM-00821·Docherty, Sarah et al. (2023). “The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study..” Nutrients.Study breakdown →PubMed →↩
5. 5RTHM-00952·Surendran, Geyan et al. (2025). “Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study..” Frontiers in nutrition.Study breakdown →PubMed →↩
6. 6RTHM-00590·Vigna, Luisella et al. (2019). “Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?.” Evidence-based complementary and alternative medicine : eCAM.Study breakdown →PubMed →↩
7. 7RTHM-00371·Friedman, Mendel (2015). “Chemistry, Nutrition, and Health-Promoting Properties of Hericium erinaceus (Lion's Mane) Mushroom Fruiting Bodies and Mycelia and Their Bioactive Compounds..” Journal of agricultural and food chemistry.Study breakdown →PubMed →↩
8. 8RTHM-00472·He, Xirui et al. (2017). “Structures, biological activities, and industrial applications of the polysaccharides from Hericium erinaceus (Lion's Mane) mushroom: A review..” International journal of biological macromolecules.Study breakdown →PubMed →↩
9. 9RTHM-00921·Contato, Alex Graça et al. (2025). “Lion's Mane Mushroom (Hericium erinaceus): A Neuroprotective Fungus with Antioxidant, Anti-Inflammatory, and Antimicrobial Potential-A Narrative Review..” Nutrients.Study breakdown →PubMed →↩
10. 10RTHM-00005·Xu, C P et al. (1985). “A double-blind study of effectiveness of hericium erinaceus pers therapy on chronic atrophic gastritis. A preliminary report..” Chinese medical journal.Study breakdown →PubMed →↩